Tags

Type your tag names separated by a space and hit enter

Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Br J Dermatol. 2004 Jul; 151(1):141-7.BJ

Abstract

BACKGROUND

The incidence of skin cancer and especially basal cell carcinoma (BCC) has increased in the last decade and is still increasing. Many treatment modalities can be used to treat BCC; surgical excision is the most frequently used. Mohs' micrographic surgery (MMS) is an advanced excision technique which is often used to treat BCC in the U.S.A. In Europe it is practised less frequently.

OBJECTIVE

The aim of this article was to evaluate the efficiency of MMS for the treatment of facial BCC.

METHODS

In a retrospective study recurrence rates after the treatment of facial BCC by MMS were estimated by reviewing the records of all patients with BCCs (620 patients with 720 BCCs) treated by MMS in our department from April 1992 until December 1999.

RESULTS

The 5-year recurrence rates estimated from this study were 3.2% for primary BCC and 6.7% for recurrent BCC. Prognostic factors for recurrence are: an aggressive histopathological subtype, more than four Mohs' stages, a large defect size and a recurrent BCC.

CONCLUSION

Based on the fact that MMS provides the lowest recurrence rates, it is the treatment of first choice for primary facial BCCs with an aggressive histopathological subtype and for recurrent BCCs in the face.

Authors+Show Affiliations

Department of Epidemiology, University of Maastricht, The Netherlands. nsme@sder.azm.nlNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

15270883

Citation

Smeets, N W J., et al. "Mohs' Micrographic Surgery for Treatment of Basal Cell Carcinoma of the Face--results of a Retrospective Study and Review of the Literature." The British Journal of Dermatology, vol. 151, no. 1, 2004, pp. 141-7.
Smeets NW, Kuijpers DI, Nelemans P, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature. Br J Dermatol. 2004;151(1):141-7.
Smeets, N. W., Kuijpers, D. I., Nelemans, P., Ostertag, J. U., Verhaegh, M. E., Krekels, G. A., & Neumann, H. A. (2004). Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature. The British Journal of Dermatology, 151(1), 141-7.
Smeets NW, et al. Mohs' Micrographic Surgery for Treatment of Basal Cell Carcinoma of the Face--results of a Retrospective Study and Review of the Literature. Br J Dermatol. 2004;151(1):141-7. PubMed PMID: 15270883.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature. AU - Smeets,N W J, AU - Kuijpers,D I M, AU - Nelemans,P, AU - Ostertag,J U, AU - Verhaegh,M E J M, AU - Krekels,G A M, AU - Neumann,H A M, PY - 2004/7/24/pubmed PY - 2004/10/20/medline PY - 2004/7/24/entrez SP - 141 EP - 7 JF - The British journal of dermatology JO - Br J Dermatol VL - 151 IS - 1 N2 - BACKGROUND: The incidence of skin cancer and especially basal cell carcinoma (BCC) has increased in the last decade and is still increasing. Many treatment modalities can be used to treat BCC; surgical excision is the most frequently used. Mohs' micrographic surgery (MMS) is an advanced excision technique which is often used to treat BCC in the U.S.A. In Europe it is practised less frequently. OBJECTIVE: The aim of this article was to evaluate the efficiency of MMS for the treatment of facial BCC. METHODS: In a retrospective study recurrence rates after the treatment of facial BCC by MMS were estimated by reviewing the records of all patients with BCCs (620 patients with 720 BCCs) treated by MMS in our department from April 1992 until December 1999. RESULTS: The 5-year recurrence rates estimated from this study were 3.2% for primary BCC and 6.7% for recurrent BCC. Prognostic factors for recurrence are: an aggressive histopathological subtype, more than four Mohs' stages, a large defect size and a recurrent BCC. CONCLUSION: Based on the fact that MMS provides the lowest recurrence rates, it is the treatment of first choice for primary facial BCCs with an aggressive histopathological subtype and for recurrent BCCs in the face. SN - 0007-0963 UR - https://www.unboundmedicine.com/medline/citation/15270883/Mohs'_micrographic_surgery_for_treatment_of_basal_cell_carcinoma_of_the_face__results_of_a_retrospective_study_and_review_of_the_literature_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0007-0963&date=2004&volume=151&issue=1&spage=141 DB - PRIME DP - Unbound Medicine ER -